GH Research PLC (GHRS)
11.99
0.00 (0.00%)
USD |
NASDAQ |
May 09, 16:00
12.00
0.00 (0.00%)
After-Hours: 20:00
GH Research Net Income (TTM): -32.32M for March 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -32.32M |
| December 31, 2023 | -35.59M |
| September 30, 2023 | -40.90M |
| June 30, 2023 | -35.69M |
| March 31, 2023 | -27.63M |
| December 31, 2022 | -22.46M |
| September 30, 2022 | -9.961M |
| Date | Value |
|---|---|
| June 30, 2022 | -11.36M |
| March 31, 2022 | -13.82M |
| December 31, 2021 | -9.202M |
| September 30, 2021 | -5.436M |
| June 30, 2021 | -3.659M |
| March 31, 2021 | -1.576M |
| December 31, 2020 | -0.446M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-40.90M
Minimum
Sep 2023
-0.446M
Maximum
Dec 2020
-17.86M
Average
-12.59M
Median
Net Income (TTM) Benchmarks
| Amarin Corp PLC | -52.60M |
| Jazz Pharmaceuticals PLC | 330.79M |
| Prothena Corp PLC | -172.40M |
| Iterum Therapeutics PLC | -38.37M |
| Mural Oncology PLC | -210.04M |